[Effect of granular serine proteases and protein kinases on cytolytic activity of lymphokine-activated killers].
L P
LP
Sashchenko
T I
TI
Luk'ianova
I I
II
Mirkina
S
S
Pongor
N V
NV
Gnuchev
D000818:Animals; D017209:Apoptosis; D003994:Bucladesine / Q000494:pharmacology; D017868:Cyclic AMP-Dependent Protein Kinases / Q000502:physiology*; D003602:Cytotoxicity, Immunologic; D053804:Granzymes; D006801:Humans; D015979:Killer Cells, Lymphokine-Activated / Q000502:physiology*; D007739:L Cells; D051379:Mice; D011493:Protein Kinase C / Q000502:physiology*; D012697:Serine Endopeptidases / Q000502:physiology*; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014407:Tumor Cells, Cultured; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology
D014409:Tumor Necrosis Factor-alpha; D003994:Bucladesine; D017868:Cyclic AMP-Dependent Protein Kinases; D011493:Protein Kinase C; D053804:Granzymes; D012697:Serine Endopeptidases; C509212:GZMA protein, human; D013755:Tetradecanoylphorbol Acetate